-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$81.77-16.48% Downside
Recent Analyst Forecasts and Stock Ratings
Gilead Sciences, Inc. Frequently Asked Questions
-
What analysts cover Gilead Sciences, Inc.?
Gilead Sciences, Inc. has been rated by research analysts at Piper Sandler, BMO Capital, Leerink Partners, Morgan Stanley, Jefferies, Goldman Sachs in the past 90 days.